Takahiro Yamazaki
Takahiro Yamazaki
Weill Cornell Medicine
Bestätigte E-Mail-Adresse bei med.cornell.edu
Titel
Zitiert von
Zitiert von
Jahr
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
M Vétizou, JM Pitt, R Daillère, P Lepage, N Waldschmitt, C Flament, ...
Science 350 (6264), 1079-1084, 2015
15282015
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide
S Viaud, F Saccheri, G Mignot, T Yamazaki, R Daillère, D Hannani, ...
science 342 (6161), 971-976, 2013
11022013
Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
A Sistigu, T Yamazaki, E Vacchelli, K Chaba, DP Enot, J Adam, I Vitale, ...
Nature medicine 20 (11), 1301-1309, 2014
5962014
Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy
C Pfirschke, C Engblom, S Rickelt, V Cortez-Retamozo, C Garris, F Pucci, ...
Immunity 44 (2), 343-354, 2016
4582016
Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells
Y Ma, S Adjemian, SR Mattarollo, T Yamazaki, L Aymeric, H Yang, ...
Immunity 38 (4), 729-741, 2013
4532013
Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and-extrinsic factors
JM Pitt, M Vétizou, R Daillère, MP Roberti, T Yamazaki, B Routy, ...
Immunity 44 (6), 1255-1269, 2016
4492016
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
R Daillère, M Vétizou, N Waldschmitt, T Yamazaki, C Isnard, ...
Immunity 45 (4), 931-943, 2016
3092016
An immunosurveillance mechanism controls cancer cell ploidy
L Senovilla, I Vitale, I Martins, M Tailler, C Pailleret, M Michaud, L Galluzzi, ...
Science 337 (6102), 1678-1684, 2012
3052012
Cardiac glycosides exert anticancer effects by inducing immunogenic cell death
L Menger, E Vacchelli, S Adjemian, I Martins, Y Ma, S Shen, T Yamazaki, ...
Science translational medicine 4 (143), 143ra99-143ra99, 2012
2672012
Caloric restriction mimetics enhance anticancer immunosurveillance
F Pietrocola, J Pol, E Vacchelli, S Rao, DP Enot, EE Baracco, S Levesque, ...
Cancer cell 30 (1), 147-160, 2016
2572016
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
T Yamazaki, D Hannani, V Poirier-Colame, S Ladoire, C Locher, A Sistigu, ...
Cell Death & Differentiation 21 (1), 69-78, 2014
1432014
A threshold level of intratumor CD8+ T-cell PD1 expression dictates therapeutic response to anti-PD1
SF Ngiow, A Young, N Jacquelot, T Yamazaki, D Enot, L Zitvogel, ...
Cancer research 75 (18), 3800-3811, 2015
1312015
Linking cellular stress responses to systemic homeostasis
L Galluzzi, T Yamazaki, G Kroemer
Nature Reviews Molecular Cell Biology 19 (11), 731-745, 2018
1222018
Harnessing γδ T cells in anticancer immunotherapy
D Hannani, Y Ma, T Yamazaki, J Dechanet-Merville, G Kroemer, ...
Trends in immunology 33 (5), 199-206, 2012
1192012
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
H Yang, Y Ma, G Chen, H Zhou, T Yamazaki, C Klein, F Pietrocola, ...
Oncoimmunology 5 (6), e1149673, 2016
922016
Crosstalk between ER stress and immunogenic cell death
O Kepp, L Menger, E Vacchelli, C Locher, S Adjemian, T Yamazaki, ...
Cytokine & growth factor reviews 24 (4), 311-318, 2013
922013
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
L Galluzzi, I Vitale, S Warren, S Adjemian, P Agostinis, AB Martinez, ...
Journal for immunotherapy of cancer 8 (1), 2020
792020
Desirable cell death during anticancer chemotherapy
C Locher, R Conforti, L Aymeric, Y Ma, T Yamazaki, S Rusakiewicz, ...
Annals of the New York Academy of Sciences 1209 (1), 99-108, 2010
782010
Immune checkpoint blockade, immunogenic chemotherapy or IFN-α blockade boost the local and abscopal effects of oncolytic virotherapy
L Fend, T Yamazaki, C Remy, C Fahrner, M Gantzer, V Nourtier, X Préville, ...
Cancer research 77 (15), 4146-4157, 2017
652017
STAT3 inhibition enhances the therapeutic efficacy of immunogenic chemotherapy by stimulating type 1 interferon production by cancer cells
H Yang, T Yamazaki, F Pietrocola, H Zhou, L Zitvogel, Y Ma, G Kroemer
Cancer research 75 (18), 3812-3822, 2015
652015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20